Downloads: 149

Files in This Item:
File Description SizeFormat 
24_0609.pdf1.8 MBAdobe PDFView/Open
Title: 前立腺肥大症に対するPhenoxybenzamineの使用経験
Other Titles: CLINICAL STUDIES ON PHENOXYBENZAMINE IN-THE TREATMENT OF BENIGN PROSTATIC HYPERTROPHY
Authors: 勝見, 哲郎  KAKEN_name
中島, 慎一  KAKEN_name
川口, 光平  KAKEN_name
村山, 和夫  KAKEN_name
北川, 清隆  KAKEN_name
金田, 泰雄  KAKEN_name
黒田, 恭一  KAKEN_name
Author's alias: Katsumi, Tetsuo
Nakajima, Shinichi
Kawaguchi, Kohei
Murayama, Kazuo
Kitagawa, Kiyotaka
Kaneda, Yasuo
Kuroda, Kyoichi
Issue Date: Jul-1978
Publisher: 京都大学医学部泌尿器科学教室
Journal title: 泌尿器科紀要
Volume: 24
Issue: 7
Start page: 609
End page: 616
Abstract: Seventeen patients with benign prostatic hypertrophy have been treated by an oral administration of phenoxybenzamine (POB) 5 mg daily for 14 days. The effectiveness was determined by scoring the relief degree of symptoms or complaints related to micturition, and by physical findings such as the amount of residual urine, uroflowmetric and cystometric patterns, and urethral pressure profile. The results obtained are as follows: 1. Relief of the symptoms or complaints was obtained in 12 patients (70.6%), and the decrease of nocturnal frequency in 13 patients (76.5%) (p<0.01). 2. The decrease of residual urine was obtained in 12 patients (70.6%). 3. The estimation of posterior urethral pressure was undertaken in 4 patients and there was no significant decrease after the administration. 4. Neither subjective nor objective side effects were observed in the patients. From the results, POB was considered a useful drug in the conservative treatment of benign prostatic hypertrophy.
URI: http://hdl.handle.net/2433/122228
Appears in Collections:Vol.24 No.7

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.